Avient Corporation Overview
Avient Corporation is a mid-capitalisation specialty polymer formulator that occupies the value-added layer between commodity resin producers and the designers, assemblers and processors who convert polymers into finished goods. It does not make base resin. It buys polyolefins, engineering thermoplastics, titanium dioxide, pigments, specialty additives and ethylene, and sells formulated colour concentrates, functional additive masterbatches, engineered compounds, advanced composites and ultra-high-molecular-weight polyethylene (UHMWPE) fibre. Roughly 61% of 2025 sales were to customers outside the United States, and no single customer accounted for more than 3% of consolidated revenue — a diversification profile that materially dampens single-account risk but also means the business is a fairly direct read on global industrial production. The company has spent fifteen years divesting cyclical, capital-intensive commodity businesses (PVC compounds, performance products and solutions, distribution) and buying formulation and fibre assets (ColorMatrix, Spartech, Fiber-Line, Clariant Masterbatch, Dyneema). Under Ashish Khandpur, who arrived from 3M in December 2023, the emphasis has shifted decisively from portfolio reshaping via M&A to organic growth through innovation in a defined set of "growth vectors" — principally defence, healthcare, telecommunications and sustainable packaging — supported by relentless productivity work. The result through mid-2026 is a company with flat-to-modest top-line growth but three consecutive years of adjusted margin expansion and de-leveraging.
Note: FY2021 and FY2023 site counts are as disclosed in the respective 10-Ks; the FY2021 figure includes the Distribution business footprint and is not strictly comparable. Regional headcount mix at 31 December 2025: US and Canada 33%, EMEA 33%, Asia 26%, Latin America 8%.
The company's own characterisation
Avient describes itself in the FY2025 Form 10-K as "an innovator of materials solutions to help our customers succeed, while enabling a sustainable world," with products spanning specialty engineered materials, performance fibres, advanced composites, and colour and additive solutions, plus performance-enhancing additives, liquid colorants and silicone colorants. Management frames the company's role as creating "an essential link between large chemical producers (our raw material suppliers) and designers, assemblers and processors of polymers (our customers)," arguing that this intermediary role becomes more valuable as customers demand global reach with local service and materials-based solutions that improve product performance, appeal, differentiation and profitability.
Independent characterisation
Avient is best understood as a formulation and applications-engineering business with a fibre franchise attached. Three structurally distinct profit pools sit under two reporting segments:
Pool 1 — Colour and additive masterbatch (the bulk of Color, Additives and Inks). High-mix, low-volume, short-lead-time concentrates sold into packaging, consumer, healthcare and industrial converters. Value is created through colour matching, formulation know-how, regulatory qualification (particularly in healthcare and food contact), and local service density. Switching costs are moderate but real, because a colour or additive package is written into a customer's specification and requalification is costly. Gross margins here are structurally attractive (segment gross margin 33.5% in FY2025) but the business is closely levered to converter volumes and therefore to consumer and industrial demand.
Pool 2 — Engineered compounds and composites (most of Specialty Engineered Materials ex-Dyneema). Longer development cycles, deeper specification lock-in, and more exposure to transportation, telecommunications, electrical/electronics, healthcare devices and building products. Products such as flame-retardant and low-smoke compounds (ECCOH), thermally and electrically conductive formulations (Therma-Tech, Stat-Tech), low-loss dielectrics (PREPERM) and long-fibre reinforced thermoplastics (Complēt) are designed into parts and generate multi-year revenue annuities.
Pool 3 — Avient Protective Materials / Dyneema. A genuinely differentiated, capacity-constrained UHMWPE fibre and unidirectional-laminate business acquired from DSM in 2022. It has the strongest brand, the highest barriers to entry (polymer chemistry plus gel-spinning process know-how), and the most attractive secular demand backdrop of anything Avient owns, driven by NATO and allied defence re-armament, law-enforcement personal protection, offshore mooring and floating offshore wind. This is where incremental capital is being directed in 2026.
Revenue model
Avient's revenue is essentially 100% product sale revenue. There is no material subscription, licensing or service revenue stream disclosed. Revenue is recognised at a point in time when control transfers, typically on shipment; sales are reduced for volume-based customer rebates estimated at the time of initial sale. Services such as ColorWorks design centres, the CycleWorks recycling innovation centre, colour-prediction and foaming-prediction tools, part and tooling design analysis, and 3D printing/rapid prototyping are offered as commercially bundled, non-separately-monetised demand-generation assets rather than fee-bearing lines. A small equipment element exists (ColorMatrix FlexCart and FlexOne liquid metering systems), typically placed to lock in liquid colorant consumption; standalone equipment revenue is not publicly disclosed.
Pricing is negotiated account-by-account, with raw-material pass-through mechanisms of varying formality. Management commentary in 2026 has repeatedly emphasised proactive pricing actions ahead of inflation, and Q2 2026 organic growth of 4.3% was attributed to a combination of share gains, new product innovation and pricing.
Route to market and value-chain position
Products are sold primarily through a direct sales force, supplemented by distributors and commissioned sales agents. Logistics is predominantly truck-based, with some customer pickup. The value chain runs: base resin producers (LyondellBasell, Dow, ExxonMobil, SABIC, BASF and others) → Avient formulation → converters and moulders → OEMs and brand owners. Avient's commercial leverage comes from being specified at the OEM/brand-owner level while selling to the converter — a "pull-through" model common in specialty additives.
Customer types and end markets
| End market | Share of FY2024 sales (%) |
|---|---|
| Packaging | 23 |
| Consumer | 20 |
| Industrial | 15 |
| Transportation | 10 |
| Building and construction | 10 |
| Healthcare | 8 |
| Defense | 7 |
| Energy | 4 |
| Telecommunications | 3 |
Customers are plastics processors (injection moulders, extruders, blow moulders, film and fibre producers), tier-one automotive and aerospace suppliers, medical device and pharmaceutical packaging manufacturers, wire and cable makers, body-armour and defence primes, and rope, netting and mooring fabricators. Nine end markets are disclosed. The FY2024 mix, the most recently published full breakdown, was:
Seasonality is modest but real: demand has historically been slower in the third and fourth quarters, and the defence business is tender- and project-driven, producing lumpy quarter-to-quarter order patterns.
Financial Narrative
All figures are continuing operations unless noted. FY2021 and FY2022 have been restated by the company to exclude the Distribution business.
Income statement
"nd" = not disclosed on a comparable continuing-operations basis in the sources reviewed. FY2022 adjusted EBITDA was reported by the company both on an as-reported continuing-operations basis and on a pro-forma basis including Avient Protective Materials for the pre-acquisition period, and the two are not comparable to the FY2023–FY2025 series; rather than estimate, both FY2021 and FY2022 are left unpopulated. FY2021–FY2023 dividends declared per share are derived from disclosed dividends paid divided by weighted-average shares and should be treated as approximate; FY2024 and FY2025 are as disclosed in the FY2025 earnings release. FY2021 and FY2022 total net income includes discontinued operations ($79.0m and $620.3m respectively, the latter including the $717.0m pre-tax gain on the Distribution sale).
Margin analysis (%)
Revenue CAGR FY2021–FY2025: –0.4% per annum. Adjusted EBITDA CAGR FY2023–FY2025: +7.2% per annum. That divergence is the single most important fact about Avient's recent financial history: the company has generated essentially all of its earnings growth from mix and cost, not volume.
Commentary on income-statement trends and inflections
FY2021 to FY2022 — inflation pass-through and portfolio surgery. Revenue rose 2.5% but gross margin fell 250bp as raw material and energy inflation outran price. The Dyneema acquisition closed 1 September, adding four months of high-margin fibre revenue; the Distribution disposal closed 1 November. Interest expense rose 59% to $119.8m on the $1.3bn of acquisition debt. GAAP results are close to meaningless in this year: the reported total EPS of $7.61 is 94% divestiture gain.
FY2022 to FY2023 — the destocking trough. Revenue fell 7.5%, driven almost entirely by CAI (–14.8%) as converters worked down inventory built during the 2021–22 supply scare. SEM grew 9.0% on a full year of Dyneema. Gross margin recovered 240bp to 28.4% as raw materials deflated faster than price, but operating income still fell 19.1% because Corporate costs rose and because $115.3m of interest expense was now embedded. Adjusted EPS of $2.36 was the cycle low. Operating cash flow collapsed to $201.6m, of which $104m of the year-on-year deterioration was cash tax paid on the Distribution gain.
FY2023 to FY2024 — the clean year. This is the only year in the five-year window where GAAP and adjusted results tell the same story. Revenue rose 3.1% with 4% organic growth, all four regions positive in Q4. Gross margin expanded 420bp to 32.6% on raw-material deflation in the first half plus volume leverage. Adjusted EBITDA margin expanded 110bp to 16.2%, with CAI up 90bp and SEM up 110bp. Adjusted EPS rose 13% to $2.66. GAAP results were flattered by a $34.7m insurance recovery of previously incurred environmental costs at Calvert City.
FY2024 to FY2025 — a tale of two income statements. Reported operating income fell 38.2% to $203.5m while adjusted operating income rose 3.4% to $362.8m. The entire gap is special items, which swung from a $21.4m charge to a $159.3m charge. The three drivers were: (i) the $86.3m of ERP-related charges — a $71.6m impairment on the abandoned S/4HANA cloud implementation plus $14.7m of unpaid contractual hosting obligations; (ii) restructuring costs of $48.4m across cost of sales and S&A, up $43.9m year on year; and (iii) the non-repeat of the $34.7m environmental insurance recovery, replaced by only $2.0m in 2025. Underlying, the business expanded adjusted EBITDA margin by 50bp to 16.7%, its third consecutive year of expansion, and grew adjusted EPS 6% to $2.82 despite organic sales declining 0.3%. Interest expense fell $7.0m on the March repricing and $150m of prepayments. The effective tax rate rose from 24.1% to 25.2% on higher GILTI and Subpart F income and valuation allowance increases.
The Corporate cost line deserves scrutiny. It has averaged roughly $190m of annual operating drag over five years and reached $261.4m in FY2025. Even excluding the ERP write-off and restructuring, the unallocated cost base is substantial for a company with $3.3bn of revenue, and it is the single largest lever management has not yet convincingly pulled.
H1 2026 — the inflection. Sales of $1,764.4m with 1.2% organic growth; adjusted EBITDA of $318.1m (18.0% margin) with 4.7% organic growth; adjusted EPS of $1.79, up 15% and up 9.1% organically. Q2 2026 alone delivered 4.3% organic growth, a record 18.3% adjusted EBITDA margin (+110bp), and 20% adjusted EPS growth. Special items collapsed to $18.2m for the half from $108.5m in H1 2025, so GAAP EPS of $1.31 versus $0.35 overstates the improvement, but the adjusted trajectory is genuine.
Balance sheet
Debt structure at 31 December 2025 (USD millions): senior secured term loan due 2029, $559.0; 7.125% senior notes due 2030, $718.8; 6.250% senior notes due 2031, $642.1; other debt, $3.2; senior secured revolving credit facility ($500m capacity, maturing 12 June 2030), zero drawn with $490.3m available after $9.7m of letters of credit. Total debt $1,923.1m. Liquidity of $1,000.8m. Note that 76% of cash resided outside the United States at year-end 2025, a meaningful constraint on frictionless deployment.
Goodwill and intangibles are the balance sheet's dominant feature. At 31 December 2025 goodwill of $1,757.6m plus net intangibles of $1,492.4m totalled $3,250.0m, or 54% of total assets and 136% of total equity. Tangible book value has been persistently negative since the Clariant deal. Management performed the annual goodwill test as at 1 October 2025 using a qualitative approach for most reporting units with quantitative testing elected for certain units; no impairment was recorded, and indefinite-lived trade names likewise passed on a qualitative basis. This is an area where a sustained downturn in CAI would create genuine risk.
Cash flow
FY2025 free cash flow of $195.0m was the strongest since 2022 and comfortably covered the $98.8m dividend (a 51% FCF payout). The FY2025 operating cash flow improvement of $44.8m was helped by three non-recurring or discrete items — $34.0m of Calvert City insurance proceeds, a $23.0m reduction in pension and deferred compensation outflows, and a $17.9m reduction in environmental remediation payments — partially offset by higher incentive payments and working capital build. Investors should therefore treat the underlying FCF run-rate as somewhat below the headline. Management guided to FY2026 free cash flow of $200–220m on capital expenditure of approximately $140m, with the ~$33m increase directed almost entirely at Dyneema capacity for defence.
Dividends and buybacks. The quarterly dividend was raised to $0.2750 per share in 2025, marking the fifteenth consecutive annual increase and an annualised rate of $1.10. No shares were repurchased in the open market in 2024 or 2025; approximately 5.0m shares remain available under the board authorisation originally approved in August 2008 and last increased on 9 December 2020. The "repurchase of common stock" line in third-party cash flow databases reflects share-award tax withholding, not buybacks.
Ratio analysis
Reading the ratios. Three things stand out. First, de-leveraging is real and consistent: net debt/adjusted EBITDA has fallen from 3.4x at the end of 2023 to 2.6x at the end of 2025, and management has stated a target of below 2.5x. Second, returns on capital remain thin. On a GAAP basis ROIC has never exceeded 7% in the period; on an adjusted basis it is roughly 7%, which is likely at or marginally below Avient's weighted average cost of capital. This is the central bear point on the stock and is a direct consequence of paying full prices for Clariant Color and Dyneema. Third, the cash conversion cycle has deteriorated by 12 days since 2021, driven by inventory days rising from 47 to 60. Some of this is deliberate — Dyneema is a longer-cycle, higher-value inventory — but H1 2026 saw a further $80.5m inventory build, and this is a line to watch.
7. SEGMENTAL AND GEOGRAPHIC REVENUE MAPPING
Fastest-growing and declining regions, with reasons
Latin America is the standout grower. Revenue rose from $158.5m in FY2021 to roughly $194m in FY2024, and organic growth reached 14% in Q4 2024 and 17% in Q1 2025. Management has attributed this to new product specifications in the colour business, particularly in Brazil and Mexico, and to a low absolute base. Avient's Latin American footprint (Argentina, Brazil ×2, Chile, Colombia, Guatemala, Mexico ×2, Peru) is disproportionately CAI-weighted, so the growth carries good incremental margin.
Asia is volatile but structurally important. It fell from $699.0m in FY2021 to $552.2m in FY2023 as China lockdowns and then domestic competitive pressure bit, then partially recovered. Q1 2025 organic growth of 9% and management's identification of Asia as the strongest region in Q2 2026 suggest the trough is behind. Avient operates twelve manufacturing sites in China plus sites in India (four), Indonesia, Malaysia, Pakistan, Singapore, Taiwan, Thailand (two) and Vietnam.
The United States and Canada is the most cyclically exposed. It represents roughly 41% of sales and declined 5% organically in Q3 2025 — the steepest of any region — on consumer and industrial weakness. It is also where the building and construction exposure is concentrated, and therefore most levered to interest rates.
EMEA is the structural question mark. European revenue has declined in absolute terms every year since 2022 and the region carries Avient's highest fixed-cost base outside North America (36 manufacturing sites across Europe plus the Netherlands-based Dyneema operations at Geleen and Heerlen). Offsetting this, EMEA is where the defence tailwind is most acute and where the August 2026 food-contact PFAS rules are generating demand for Avient's non-PFAS processing aids.
Segment-by-geography revenue is not disclosed. Avient reports segment revenue and geographic revenue separately but does not cross-tabulate them. Analytically, CAI is the more geographically balanced business; SEM's Dyneema component is heavily European in manufacturing origin (Netherlands) with global end-market distribution skewed to NATO members.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Sales (USD Mn) | 3,315.5 | 3,396.9 | 3,142.8 | 3,240.4 | 3,260.2 |
Cost of sales (USD Mn) | 2,371.7 | 2,514.2 | 2,250.3 | 2,183.7 | 2,244.6 |
Gross profit (USD Mn) | 943.8 | 882.7 | 892.5 | 1,056.7 | 1,015.6 |
Selling and administrative expense (USD Mn) | 664.1 | 639.4 | 695.7 | 727.4 | 812.1 |
Operating income, GAAP (USD Mn) | 279.7 | 243.3 | 196.8 | 329.3 | 203.5 |
Adjusted operating income (USD Mn) | — | — | — | 350.7 | 362.8 |
EBITDA, GAAP (USD Mn) | 423.8 | 346.1 | 391.4 | 510.1 | 396.2 |
Adjusted EBITDA (USD Mn) | — | — | 474.0 | 526.4 | 544.6 |
Interest expense, net (USD Mn) | 75.2 | 119.8 | 115.3 | 105.6 | 98.6 |
Pre-tax income, continuing ops (USD Mn) | 203.5 | 63.8 | 87.3 | 224.8 | 111.7 |
Income tax expense/(benefit) (USD Mn) | 51.9 | -19.3 | 11.0 | 54.1 | 28.1 |
Net income, continuing ops (USD Mn) | 151.6 | 83.1 | 76.3 | 170.7 | 83.6 |
Net income attributable to Avient, total (USD Mn) | 230.0 | 701.7 | 75.7 | 169.5 | 81.9 |
Basic EPS, total (USD) | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 |
Diluted EPS, total (USD) | 2.50 | 7.61 | 0.83 | 1.84 | 0.89 |
Adjusted diluted EPS (USD) | — | 2.69 | 2.36 | 2.66 | 2.82 |
Dividends declared per share (USD) | 0.855 | 0.953 | 0.990 | 1.0425 | 1.0850 |
Diluted weighted-average shares (M) | 92.0 | 92.2 | 91.5 | 92.0 | 91.8 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 28.5 | 26.0 | 28.4 | 32.6 | 31.2 |
Adjusted gross margin (%) | — | — | — | 32.6 | 32.5 |
Operating margin, GAAP (%) | 8.4 | 7.2 | 6.3 | 10.2 | 6.2 |
Adjusted operating margin (%) | — | — | — | 10.8 | 11.1 |
EBITDA margin, GAAP (%) | 12.8 | 10.2 | 12.5 | 15.7 | 12.2 |
Adjusted EBITDA margin (%) | — | — | 15.1 | 16.2 | 16.7 |
Net margin, continuing ops (%) | 4.6 | 2.4 | 2.4 | 5.3 | 2.6 |
S&A expense as % of sales | 20.0 | 18.8 | 22.1 | 22.4 | 24.9 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash and equivalents (USD Mn) | 601.2 | 641.1 | 545.8 | 544.5 | 510.5 |
Accounts receivable, net (USD Mn) | 439.9 | 440.6 | 399.9 | 399.5 | 435.0 |
Inventories, net (USD Mn) | 305.8 | 372.7 | 347.0 | 346.8 | 367.2 |
Total current assets (USD Mn) | 1,827.0 | 1,570.0 | 1,408.0 | 1,422.1 | 1,400.9 |
Property, net (USD Mn) | 730.5 | 1,110.0 | 1,094.0 | 955.3 | 988.8 |
Goodwill (USD Mn) | 1,284.8 | 1,671.9 | 1,719.3 | 1,659.7 | 1,757.6 |
Intangible assets, net (USD Mn) | 925.2 | 1,597.6 | 1,591.0 | 1,450.4 | 1,492.4 |
Total assets (USD Mn) | 4,997.2 | 6,085.0 | 5,968.5 | 5,811.1 | 6,025.6 |
Accounts payable (USD Mn) | 429.5 | 454.4 | 432.3 | 417.4 | 410.0 |
Total current liabilities (USD Mn) | 940.6 | 869.4 | 773.6 | 756.1 | 846.3 |
Short-term and current portion of LT debt (USD Mn) | 11.7 | 2.2 | 9.5 | 7.7 | 0.5 |
Long-term debt (USD Mn) | 1,850.0 | 2,177.0 | 2,071.0 | 2,059.3 | 1,922.6 |
Total debt incl. finance and operating leases (USD Mn) | 1,920.0 | 2,237.0 | 2,140.0 | 2,149.0 | 2,000.0 |
Net debt (USD Mn) | 1,318.8 | 1,595.9 | 1,594.2 | 1,604.5 | 1,489.5 |
Deferred income tax liabilities (USD Mn) | 100.6 | 342.5 | 281.6 | 260.4 | 285.7 |
Total liabilities (USD Mn) | 3,206.0 | 3,732.2 | 3,630.5 | 3,481.5 | 3,639.3 |
Avient shareholders' equity (USD Mn) | 1,775.0 | 2,334.5 | 2,319.2 | 2,313.8 | 2,374.2 |
Total equity incl. NCI (USD Mn) | 1,791.0 | 2,352.8 | 2,338.0 | 2,329.6 | 2,386.3 |
Working capital (USD Mn) | 886.4 | 700.3 | 634.4 | 666.0 | 554.6 |
Book value per share (USD) | 19.37 | 25.68 | 25.43 | 25.32 | 25.92 |
Tangible book value per share (USD) | -4.75 | -10.29 | -10.87 | -8.71 | -9.56 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (USD Mn) | 233.8 | 398.4 | 201.6 | 256.8 | 301.6 |
Capital expenditures (USD Mn) | 100.6 | 105.5 | 119.4 | 121.9 | 106.6 |
Free cash flow (USD Mn) | 133.2 | 292.9 | 82.2 | 134.9 | 195.0 |
Cash dividends paid (USD Mn) | 77.7 | 86.8 | 90.2 | 94.0 | 98.8 |
Share repurchases (open market) (USD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Payments for withholding tax on share awards (USD Mn) | 14.9 | 40.7 | 3.4 | 6.4 | 4.1 |
Long-term debt issued (USD Mn) | 0.0 | 1,300.0 | 0.0 | 650.0 | 0.0 |
Long-term debt repaid (USD Mn) | 18.5 | 956.8 | 105.8 | 660.9 | 150.3 |
Cash acquisitions (USD Mn) | 47.6 | 1,426.0 | 0.0 | 0.0 | 0.0 |
Divestiture proceeds (USD Mn) | 0.0 | 928.2 | 7.3 | 0.0 | 0.0 |
Depreciation and amortisation (USD Mn) | 144.2 | 163.1 | 188.8 | 179.7 | 185.9 |
Cash interest paid (USD Mn) | 72.6 | 69.4 | 106.3 | 85.2 | 97.6 |
Cash income taxes paid (USD Mn) | 89.5 | 80.3 | 151.2 | 65.9 | 65.8 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Return on equity, year-end basis (%) | 12.8 | 29.8 | 3.2 | 7.3 | 3.4 |
Return on assets, year-end basis (%) | 4.6 | 11.6 | 1.3 | 2.9 | 1.4 |
ROIC, GAAP operating income basis (%) | 6.7 | 4.6 | 4.4 | 6.4 | 3.9 |
ROIC, adjusted operating income basis (%) | — | — | — | 6.8 | 7.0 |
Current ratio (x) | 1.94 | 1.81 | 1.82 | 1.88 | 1.66 |
Quick ratio (x) | 1.62 | 1.38 | 1.37 | 1.42 | 1.22 |
Total debt to equity (x) | 1.07 | 0.95 | 0.92 | 0.92 | 0.84 |
Net debt to adjusted EBITDA (x) | — | 2.9 | 3.4 | 3.0 | 2.6 |
Interest coverage, adj. EBITDA / net interest (x) | — | — | 4.1 | 5.0 | 5.5 |
Asset turnover (x) | 0.66 | 0.56 | 0.53 | 0.56 | 0.54 |
Days sales outstanding | 48.4 | 47.3 | 46.4 | 45.0 | 48.7 |
Days inventory outstanding | 47.1 | 54.1 | 56.3 | 58.0 | 59.7 |
Days payables outstanding | 66.1 | 66.0 | 70.1 | 69.8 | 66.7 |
Cash conversion cycle (days) | 29.4 | 35.4 | 32.6 | 33.2 | 41.7 |
Effective tax rate (%) | 25.5 | -30.3 | 12.6 | 24.1 | 25.2 |
Free cash flow conversion, FCF / adj. EBITDA (%) | — | — | 17.3 | 25.6 | 35.8 |
Dividend payout, dividends paid / FCF (%) | 58.3 | 29.6 | 109.7 | 69.7 | 50.7 |
Key Financials
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
United States and Canada (USD Mn) | 1,262.3 | 1,372.9 | 1,271.2 | 1,328.6 | — |
Europe (EMEA) (USD Mn) | 1,195.7 | 1,213.1 | 1,151.9 | 1,134.1 | — |
Asia (USD Mn) | 699.0 | 630.8 | 552.2 | 583.3 | — |
Latin America (USD Mn) | 158.5 | 180.1 | 167.5 | 194.4 | — |
Total (USD Mn) | 3,315.5 | 3,396.9 | 3,142.8 | 3,240.4 | 3,260.2 |
Margin Analysis (%) (FY2021–FY2024)
| Region | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
United States and Canada (%) | 38.1 | 40.4 | 40.4 | 41.0 |
Europe / EMEA (%) | 36.1 | 35.7 | 36.7 | 35.0 |
Asia (%) | 21.1 | 18.6 | 17.6 | 18.0 |
Latin America (%) | 4.8 | 5.3 | 5.3 | 6.0 |
Margin Analysis (%) (Quarterly)
| Region | Q4 2024 | Q1 2025 | Q3 2025 |
|---|---|---|---|
United States and Canada (%) | 6 | -3 | -5 |
EMEA (%) | 1 | 2 | -3 |
Asia (%) | 7 | 9 | -1 |
Latin America (%) | 14 | 17 | 1 |
Key Financials (FY2021–FY2023)
| Region | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
United States and Canada (USD Mn) | 273.5 | 513.4 | 506.4 |
Europe (USD Mn) | 172.4 | 272.2 | 284.2 |
Asia (USD Mn) | 198.5 | 237.1 | 208.9 |
Latin America (USD Mn) | 27.9 | 26.5 | 29.4 |
Total (USD Mn) | 672.3 | 1,049.2 | 1,028.9 |
Valuation Snapshot
| Metric | Value |
|---|---|
Recent price | $41.90 (9 September 2026 close); $43.53 intraday 4 September 2026 |
52-week range | $27.48 to $44.85 |
Trailing one-year return | Approximately +19.5%, versus roughly +0.9% for the industry (as at 31 August 2026) |
Price at 30 June 2025 | $32.31 (used for the FY2025 10-K non-affiliate market value calculation of $3.0bn) |
Price at 13 February 2026 | Approximately $41.84 close, following a roughly 10% single-day gain on FY2025 results |
Price around Q1 2026 results (8 May 2026) | Approximately $38.50 |
Price around Q2 2026 results (7 August 2026) | Approximately $38.67 pre-market |
Twelve-month low and high through mid-2025 | $27.86 to $54.68 |
Beta (five-year monthly) | 1.34 to 1.44 depending on measurement date |
Average daily volume | Approximately 848,000 shares |
Short interest | Approximately 1.7m shares, or under 2% of shares outstanding |
Last stock split | 1 September 2000, two-for-one forward |
Valuation Multiples
| Multiple | Calculation basis | Value |
|---|---|---|
Market capitalisation | 91.72m shares × $41.90 | approximately $3.84bn |
Net debt (30 June 2026) | $1,875.8m total debt less $425.6m cash | approximately $1.45bn |
Enterprise value | Market cap plus net debt plus $13.1m NCI | approximately $5.30bn |
EV / FY2025 adjusted EBITDA | $5.30bn / $544.6m | 9.7x |
EV / FY2026E adjusted EBITDA (guidance midpoint $589m) | $5.30bn / $589m | 9.0x |
EV / Sales (FY2026E ~$3.5bn) | — | approximately 1.5x |
EV / Sales (FY2025 actual) | $5.30bn / $3.26bn | 1.63x |
P/E on FY2025 GAAP diluted EPS | $41.90 / $0.89 | 47.1x |
P/E on FY2025 adjusted EPS | $41.90 / $2.82 | 14.9x |
P/E on FY2026E adjusted EPS (guidance midpoint $3.175) | $41.90 / $3.175 | 13.2x |
P/E on FY2027E consensus EPS ($3.36, KeyCorp) | $41.90 / $3.36 | 12.5x |
P/B | $3.84bn / $2.45bn total equity (30 June 2026) | 1.57x |
Price / tangible book | negative tangible book value | not meaningful |
Free cash flow yield (FY2025) | $195m / $3.84bn | 5.1% |
Free cash flow yield (FY2026E $210m midpoint) | $210m / $3.84bn | 5.5% |
Dividend yield | $1.10 annualised / $41.90 | 2.6% |
Source and Date Details
| Source and date | Rating | Price target | Notes |
|---|---|---|---|
MarketBeat consensus (July 2025) | Moderate Buy | $48.60 average | Two hold, four buy, one strong buy |
Stockanalysis.com (mid-2025) | Strong Buy | $49.40 average | Implied 48% upside from the then-price |
Yahoo Finance (February 2026) | — | $45.25 one-year target estimate | Forward P/E of 14.53 at the time |
Wells Fargo (13 February 2026) | Overweight | $47.00, raised from $42.00 | Post-FY2025 results |
Morgan Stanley (13 February 2026) | — | $45.00 | Previously equal weight at $41.00 (12 May 2025), itself cut from $51.00 |
Deutsche Bank (14 February 2025) | Buy | $50.00, raised from $45.00 | — |
Baird (14 March 2025) | Hold (upgrade) | — | — |
KeyCorp (March 2026) | Sector Weight | — | FY2026E EPS $3.08, FY2027E EPS $3.36; Q2 2026E $0.90, Q3 2026E $0.74, Q4 2026E $0.62 |
Zacks (December 2025 / August 2026) | Upgraded strong sell to hold (Dec 2025); Zacks Rank #2 (Buy) as of late August 2026 | — | — |
Wall Street Zen (21 February 2026) | Upgraded hold to buy | — | — |
Dividends & Capital Returns and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends paid (USD Mn) | 77.7 | 86.8 | 90.2 | 94.0 | 98.8 |
Dividends declared per share (USD) | 0.855 | 0.953 | 0.990 | 1.0425 | 1.0850 |
Year-on-year increase in declared DPS (%) | — | 11.4 | 3.9 | 5.3 | 4.1 |
Dividends paid as % of free cash flow | 58.3 | 29.6 | 109.7 | 69.7 | 50.7 |
Credit Ratings
| Agency | Instrument | Rating | Date |
|---|---|---|---|
Moody's | Senior secured term loan | Baa3 (upgraded) | September 2025 |
Moody's | Senior unsecured notes | Ba3 (maintained) | September 2025 |
Moody's | Speculative Grade Liquidity | SGL-1 (maintained) | September 2025 |
Moody's | Corporate Family Rating | — | — |
S&P Global Ratings | All instruments | — | — |
Fitch Ratings | All instruments | — | — |
Obligation Details
| Obligation | Total | Less than 1 year | 1 to 3 years | 3 to 5 years | More than 5 years |
|---|---|---|---|---|---|
Total debt | 1,948.9 | 0.5 | 0.8 | 1,296.6 | 651.0 |
Interest on debt obligations | 585.1 | 124.9 | 244.0 | 195.8 | 20.4 |
Operating leases | 95.0 | 22.8 | 32.1 | 13.3 | 26.8 |
Pension and post-retirement obligations | 70.2 | 7.9 | 14.5 | 14.7 | 33.1 |
Purchase obligations | 118.5 | 67.6 | 44.2 | 4.5 | 2.2 |
Environmental remediation obligations | 141.2 | 28.1 | 57.0 | 35.3 | 20.8 |
Total material cash requirements | 2,958.9 | 251.8 | 392.6 | 1,560.2 | 754.3 |
Catalyst / Monitorable Details
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
Q3 2026 results | Late October / early November 2026 | Whether Q2's 18.3% margin holds seasonally; volume versus price decomposition of organic growth |
Q4 and FY2026 results plus FY2027 guidance | February 2027 | Whether management guides FY2027 above the 100–200bp-above-GDP framework; the first year in which the Dyneema capacity investment should contribute |
Volume inflection in consumer, industrial and building and construction | Continuous | These markets, roughly 45% of sales, were assumed flat at the low end of guidance. Any recovery is pure upside |
Dyneema capacity ramp | 2026–2027 | Timing and cost of the ~$33m incremental capex; whether the capacity is contracted before it is built |
Non-PFAS revenue disclosure | Quarterly calls | Management sized it at "several million dollars" in 2026. A move to a disclosed, double-digit-million run rate would validate the regulation-driven thesis |
Net leverage crossing 2.5x | Late 2026 / 2027 | The trigger for resumed share repurchase and a probable catalyst for a rating action on the unsecured notes |
Corporate cost normalisation | FY2026 full year | Whether Corporate reverts toward the ~$135m of FY2024 or settles structurally higher |
Goodwill testing | 1 October 2026 | Whether any reporting unit moves from qualitative to quantitative testing |
Environmental accrual movement | Quarterly | The $141.2m obligation and the Calvert City remedial design process; the company warns adjustments "have been material… in the past" |
Tariff and trade policy developments | Continuous | Direct margin and demand impact given the 61% international revenue mix |
CFO transition execution | Through 2027 | First full guidance cycle under Joe Di Salvo; whether capital allocation policy shifts |
Proxy advisory recommendations | Spring 2027 | Whether the board's public rejection of the 30% gender-diversity guideline draws against recommendations for Mr. Fearon |
Raw material and freight cost direction | Continuous | Pricing has driven much of 2026 organic growth; deflation would reverse the mix benefit |
Executive Leadership
Executive Leadership Team
| Name | Age | Title | Appointed | Prior background |
|---|---|---|---|---|
Ashish K. Khandpur, Ph.D. | 58 | Chairman, President and Chief Executive Officer | CEO and Director Dec 2023; Chairman May 2025 | 28 years at 3M: Group President, Transportation and Electronics (Apr 2021–Nov 2023); EVP Transportation and Electronics (2019–2021); EVP Electronics and Energy (2017–2019); SVP R&D and Chief Technology Officer (2014–2017) |
Giuseppe (Joe) Di Salvo | 48 | Senior Vice President and Chief Financial Officer | 1 June 2026 | ~15 years at Avient across Corporate Controller, VP Investor Relations, VP Treasurer, and leadership of Treasury and FP&A from 2019; began career at Deloitte & Touche LLP in 2001; BSBA and Accounting, The Ohio State University Fisher College of Business |
Philip G. Clark, Jr., Ph.D. | 56 | Senior Vice President and Chief Technology Officer | November 2024 | SVP and CTO, Nouryon (2022–2024); 17 years at 3M including VP R&D, Automotive and Aerospace Solutions (2019–2022) and Technical Director, Corporate Research Process Laboratory |
Kristen A. Gajewski | 44 | Senior Vice President and Chief Human Resources Officer | February 2023 | Internal: Global HR Director, Talent Management and Corporate Functions; Global HR Director, CAI (2017–2022) including an EMEA and India assignment; previously AkzoNobel Decorative Coatings (2009–2013) |
Michael J. Irwin | 47 | Senior Vice President, New Business Development and Marketing Excellence | October 2024 | 22 years at 3M, most recently VP, Abrasive Systems Division (2018–2024) |
Woon Keat Moh | 52 | Senior Vice President and President, Color, Additives and Inks | July 2024 (global); Jan 2020 in earlier CAI leadership roles | Internal since 2010; previously Clariant AG (1999–2010) and Bayer AG Specialty Products (1997–1999) |
Nello Rizzo | 58 | Senior Vice President, Global Supply Chain | January 2026 | SVP and Chief Supply Chain Officer, Momentive Performance Materials (2014–2025); earlier operations roles at PPG Industries, 3M, ThyssenKrupp and ENEL SpA |
Amy M. Sanders | 53 | Senior Vice President, General Counsel, Secretary and Corporate Ethics Officer | April 2024 | SVP and Deputy Chief Legal Officer, Global Operations, Eaton Corporation (2023–2024); 20 years at 3M including SVP and Deputy General Counsel, Business Counsel (2022–2023) and VP and General Counsel, Transportation and Electronics (2017–2022) |
David Schneider | 56 | Senior Vice President and President, Specialty Engineered Materials | September 2025 | Nearly 33 years at 3M including VP, Electronics Materials Solutions Division (2022–2025) and VP, Automotive Aftermarket Division (2018–2022) |
Executive Leadership Team — Robert M. Patterson
| Name | Role | Departure | Context |
|---|---|---|---|
Robert M. Patterson | Chairman, President and CEO | 1 December 2023 (retired); Special Advisor until 31 May 2024 | Orderly, long-planned succession after nearly a decade as CEO |
Jamie A. Beggs | Senior Vice President and CFO | 1 June 2026 | Resigned to pursue other professional opportunities; the 8-K filed 27 April 2026 expressly stated the decision was not due to any disagreement over operations, policies or practices. Tenure of approximately 5.8 years from August 2020 |
Chris L. Pederson | President, Specialty Engineered Materials | Prior to September 2025 | Succeeded by David Schneider; departure date and terms not disclosed in the sources reviewed |
Lisa K. Kunkle | Senior Vice President, General Counsel and Secretary | 2,024 | Succeeded by Amy Sanders in April 2024 |
Joel R. Rathbun | Senior Vice President, Mergers and Acquisitions | 2024–2025 | Consistent with the strategic de-emphasis of M&A; departure not separately announced in the sources reviewed |
Executive Leadership Team — Ashish K. Khandpur
| Name | Age | Director since | Independent | Committees | Principal background | Other current public boards |
|---|---|---|---|---|---|---|
Ashish K. Khandpur | 58 | 2023 | No | Innovation and Sustainability (member) | Chairman, President and CEO of Avient; formerly 3M Group President | Constellation Energy Corporation |
Richard H. Fearon | 70 | 2004 | Yes | Governance and Corporate Responsibility (Chair), Compensation and Talent | Lead Director; retired Vice Chairman and Chief Financial and Planning Officer, Eaton plc (CFO from 2002, Vice Chairman 2009–2021) | Waters Corporation, Crown Holdings, CRH plc |
Robert E. Abernathy | 71 | 2018 | Yes | Audit, Compensation and Talent | Retired Chairman and CEO, Halyard Health (2014–2017); previously Kimberly-Clark | Haemonetics Corporation |
Gregory J. Goff | 69 | 2011 | Yes | Compensation and Talent, Innovation and Sustainability | Retired energy executive; not standing for re-election at the 14 May 2026 annual meeting for personal reasons unrelated to Avient | — |
Neil Green | 56 | 2021 | Yes | Audit, Innovation and Sustainability | EVP and Chief Digital Officer, Otis Worldwide (since 2020); previously VP Data Center Group, Intel and President, Intel Federal LLC | — |
William R. Jellison | 68 | 2015 | Yes | Audit, Governance and Corporate Responsibility | Former VP and CFO, Stryker (2013–2016); former SVP and CFO, Dentsply (1998–2013); Senior Advisor, Astor Place Holdings | Anika Therapeutics, Medtronic plc |
Sandra Beach Lin | 68 | 2013 | Yes | Compensation and Talent, Governance and Corporate Responsibility | Retired President and CEO, Calisolar; formerly Corporate EVP, Celanese; senior roles at Avery Dennison, Alcoa, Honeywell | American Electric Power, Trinseo PLC |
Kim Ann Mink, Ph.D. | 66 | 2017 | Yes | Innovation and Sustainability (Chair), Compensation and Talent | Former Chairman, President and CEO, Innophos Holdings (2015–2020); formerly Business President at Dow and CEO of ANGUS Chemical | Eastman Chemical, Air Liquide S.A. |
Ernest Nicolas | 48 | 2021 | Yes | Audit, Innovation and Sustainability | Chief Enterprise Operations Officer, HP Inc. (since 2024); previously Chief Supply Chain Officer at HP and Rockwell Automation | — |
Kerry J. Preete | 65 | 2013 | Yes | Compensation and Talent (Chair), Governance and Corporate Responsibility | Retired EVP and Chief Strategy Officer, Monsanto (2010–2018) | Corteva, Inc. |
Patricia Verduin, Ph.D. | 66 | 2019 | Yes | Audit, Innovation and Sustainability | Retired Chief Technology Officer, Colgate-Palmolive (2011–2022); previously ConAgra Foods and Grocery Manufacturers Association | FMC Corporation, Ingredion, Reckitt Benckiser Group PLC |
William A. Wulfsohn | 64 | 2011 | Yes | Audit (Chair), Governance and Corporate Responsibility | Former Chairman and CEO, Ashland Global Holdings (2015–2019); former President and CEO, Carpenter Technology (2010–2014) | Modine Manufacturing |
“—” = not publicly disclosed.
Directors' Remuneration
| Executive | Salary component | Total compensation (USD) |
|---|---|---|
Ashish K. Khandpur (CEO) | approximately 15.3% of total | 6,903,295 |
Average of non-PEO named executive officers | not disclosed separately | 2,215,132 |
Major Shareholders
| Holder | Shares | % of class |
|---|---|---|
The Vanguard Group | 30,784,040 | approximately 14.1 |
BlackRock, Inc. | 26,442,290 | 12.08 |
State Street Corporation | 12,944,145 | 5.92 |
Cohen & Steers, Inc. | 11,398,208 | 5.21 |
Governance Timeline
| Date | Initiative | Detail and target |
|---|---|---|
| 2024 | New strategy and purpose unveiled | Two-pronged approach and four strategic drivers formally adopted |
| 2024 | Long-term financial framework articulated | Grow organic sales 100–200 basis points above GDP, with margin expansion, by leveraging high-growth markets and secular trends |
Aug 2024 | Debt refinancing | $650m 6.250% senior notes due 2031 issued; $650m 5.750% notes due 2025 redeemed; term loan repriced 50bp lower |
Oct 2024 – Sep 2025 | Executive team rebuild | New CTO, new head of new business development, new General Counsel, new SEM President |
Jan 2025 | Dyneema HB330 and HB332 hard ballistic launch | Third-generation UD materials enabling up to 45% weight reduction in armour systems |
Mar 2025 | Term loan repricing | Further 25bp reduction; rate now Adjusted Term SOFR + 1.75% or Base Rate + 0.75% |
May 2025 | Board leadership recombination | Khandpur becomes Chairman; Fearon becomes Lead Director |
Jun 2025 | New revolving credit facility | $500m, maturing 12 June 2030, $250m accordion, JPMorgan agent |
| 2025 | S/4HANA cloud ERP programme terminated | $71.6m impairment plus $14.7m hosting obligations; a decisive but costly reversal of the prior digital roadmap |
| 2025 | Company-wide productivity programme | Sourcing, operations, cost control and footprint optimisation; delivered 50bp of adjusted EBITDA margin expansion |
| 2025 | Debt reduction programme | $150m of voluntary term-loan prepayments; net leverage to 2.6x |
| 2025 | Three new 2030 sustainability goals introduced | Safety, water stewardship and community engagement, added to the existing climate, waste and sourcing goals |
| 2025 | Avient Leadership Behaviors launched | Six behaviours applying to all employees |
Feb 2026 | Dyneema capacity expansion announced | Near-term capacity unlocked from existing lines through innovation; incremental capital over two years; FY2026 capex raised to ~$140m, an increase of ~$33m largely for defence |
Feb 2026 | Explicit M&A pause | Management stated no M&A expected in the next 12 months and a net leverage target below 2.5x |
| 2026 | Non-PFAS product platform commercialisation | Cesa™ Non-PFAS Process Aid for Extrusion, Cesa™ Solvent Barrier Technology for HDPE, and Colorant Chromatics™ Evoluscend™ non-PFAS mould release, positioned against EU food-contact rules effective August 2026 and voluntary brand-owner PFAS reduction. Management characterised the business as "several million dollars this year" but expected to grow as customer qualification programmes advance |
Jun 2026 | Therma-Tech™ natural graphite grades | Thermally conductive formulations supporting lightweighting and electrification |
Jun 2026 | PREPERM™ low-loss dielectric thermoplastics launch | Targeting 5G/6G mmWave radomes and ADAS |
Jul 2026 | Dyneema DM20 ClassNK type approval | Qualification for floating offshore wind turbine mooring |
Aug/Sep 2026 | Dyneema SK80 launch at SMM 2026 | At least twice the durability and fatigue resistance of SK78 in mooring |
Governance Overview
| Metric | FY2026 initial guidance (12 Feb 2026) | FY2026 raised guidance (6 Aug 2026) |
|---|---|---|
Adjusted EBITDA (USD Mn) | 555 to 585 | 575 to 603 |
Implied adjusted EBITDA growth (%) | 2 to 7 | 6 to 11 |
Adjusted EPS (USD) | 2.93 to 3.17 | 3.10 to 3.25 |
Implied adjusted EPS growth (%) | 4 to 12 | 10 to 15 |
Free cash flow (USD Mn) | above 200 (200 to 220 per call detail) | above 200 |
Capital expenditure (USD Mn) | approximately 140 | approximately 140 |
Debt repayment (USD Mn) | not initially specified | 100 to 150 |
Competitive Landscape
Key Competitors
| Competitor | Ownership | Positioning versus Avient |
|---|---|---|
Ampacet Corporation | Private (US) | The largest pure-play global masterbatch producer; deeper in commodity white/black masterbatch; direct overlap in packaging and film |
Clariant AG (Clariant Additives, post-Color divestiture) | Listed (SIX: CLN) | Sold its Color masterbatch business to Avient in 2020 but retains a substantial polymer additives franchise (flame retardants, waxes, light stabilisers); now more supplier-adjacent than head-to-head in colour |
Cabot Corporation | Listed (NYSE: CBT) | Carbon black and specialty compounds; overlaps in black masterbatch and conductive compounds |
Vibrantz Technologies (formerly Ferro, Prince, Chromaflo) | Private, American Securities | Pigments and colour solutions; overlaps in dispersions and colour systems |
Milliken & Company | Private (US) | Clarifiers, additives and colorants; a direct and technically formidable competitor in polypropylene clarification and additive performance |
Tosaf Group | Private (Israel, Megides/ICL) | Fast-growing global masterbatch and additive producer; aggressive on price in EMEA and Asia |
Plastika Kritis | Listed (Athens) | European masterbatch, notably agricultural film additives |
Sukano AG | Private (Switzerland) | Specialty masterbatch for PET, PLA and specialty polyesters; overlaps in packaging |
Kingfa Sci. & Tech. | Listed (Shenzhen) | Chinese compounding and masterbatch scale player; the principal competitive threat in Asia and increasingly in export markets |
PolyOne/Avient regional and local niche producers | Various | Fragmented long tail of local colour houses; Avient's 10-K explicitly cites competition from "global companies and local niche producers" |
Celanese Corporation (Engineered Materials) | Listed (NYSE: CE) | Much larger engineered-materials franchise with backward integration into POM, LCP and nylon; direct competitor in automotive, medical and electronics compounds |
Envalior (DSM Engineering Materials + Lanxess High Performance Materials) | Private, Advent-backed | Created 2023; a direct competitor in engineering plastics and, notably, a corporate cousin to Dyneema's former parent |
SABIC Specialties | State-owned (Saudi Arabia) | Backward-integrated engineering resin producer competing on cost and scale |
Kraton Corporation (DL Chemical) | Private | Styrenic block copolymers; direct competitor to the Versaflex/Dynaflex TPE range |
Teknor Apex | Private (US) | TPEs, vinyl and engineering compounds; among the closest US analogues to Avient's SEM compounding business |
RTP Company | Private (US) | Custom engineered thermoplastic compounds including conductive, EMI shielding and long-fibre; arguably the single closest competitor to Avient's Edgetek/Complēt/Stat-Tech ranges |
Mitsubishi Chemical Group | Listed (Tokyo) | Broad engineering plastics and composites |
Ravago Group | Private (Belgium) | Compounding plus distribution; competes in both compounds and, formerly, in Avient's divested distribution channel |
Avon/Trinseo, Ascend, Domo Chemicals | Various | Regional engineering-plastics competitors, particularly in polyamide |
Honeywell International (Spectra® / Spectra Shield®) | Listed (NYSE: HON) | The only Western competitor of comparable technical standing; Dyneema and Spectra together account for a significant share of global UHMWPE fibre capacity |
Teijin Aramid (Twaron®, Endumax®) | Subsidiary of Teijin (Tokyo) | Para-aramid and UHMWPE tape; competes on a materials-substitution basis in armour |
DuPont (Kevlar®) | Listed (NYSE: DD) | Para-aramid incumbent in soft armour; simultaneously an Avient supplier via the Fiber-Line Kevlar distribution programme |
Toyobo (Izanas®) | Listed (Tokyo) | Japanese UHMWPE fibre producer |
Mitsui Chemicals (Tekmilon®) | Listed (Tokyo) | UHMWPE fibre |
Chinese UHMWPE producers (Zhongke Xinxing, Shanghai Lianle and others) | Various | Rapidly expanding capacity at lower price points; the principal medium-term margin threat to the Dyneema franchise, though qualification barriers in Western defence procurement remain high |
Peer Comparison FY2025
| Metric | Avient (FY2025) | Celanese | Cabot | Clariant |
|---|---|---|---|---|
Revenue (USD Bn) | 3.26 | nv | nv | nv |
Revenue growth, latest FY (%) | 0.6 | nv | nv | nv |
Adjusted EBITDA margin (%) | 16.7 | nv | nv | nv |
GAAP operating margin (%) | 6.2 | nv | nv | nv |
R&D as % of sales | 3.0 | nv | nv | nv |
Net debt / adjusted EBITDA (x) | 2.6 | nv | nv | nv |
Employees | 9,000 | nv | nv | nv |
Recent Developments
--
